annual CAPEX:
$3.08M-$2.54M(-45.26%)Summary
- As of today (September 10, 2025), XENE annual capital expenditures is $3.08 million, with the most recent change of -$2.54 million (-45.26%) on December 31, 2024.
- During the last 3 years, XENE annual CAPEX has risen by +$1.02 million (+50.00%).
- XENE annual CAPEX is now -45.26% below its all-time high of $5.62 million, reached on December 31, 2023.
Performance
XENE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$160.70K+$117.70K(+273.72%)Summary
- As of today (September 10, 2025), XENE quarterly capital expenditures is $160.70 thousand, with the most recent change of +$117.70 thousand (+273.72%) on June 1, 2025.
- Over the past year, XENE quarterly CAPEX has dropped by -$1.34 million (-89.30%).
- XENE quarterly CAPEX is now -92.72% below its all-time high of $2.21 million, reached on March 31, 2023.
Performance
XENE quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.53M-$1.34M(-46.78%)Summary
- As of today (September 10, 2025), XENE TTM capital expenditures is $1.53 million, with the most recent change of -$1.34 million (-46.78%) on June 1, 2025.
- Over the past year, XENE TTM CAPEX has dropped by -$1.38 million (-47.41%).
- XENE TTM CAPEX is now -78.85% below its all-time high of $7.22 million, reached on September 30, 2023.
Performance
XENE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XENE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.3% | -89.3% | -47.4% |
| 3 y3 years | +50.0% | -70.3% | +4.6% |
| 5 y5 years | +148.0% | -54.6% | -7.5% |
XENE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.3% | +50.0% | -92.7% | +4020.5% | -78.8% | +4.6% |
| 5 y | 5-year | -45.3% | +148.0% | -92.7% | +4020.5% | -78.8% | +4.6% |
| alltime | all time | -45.3% | +1871.2% | -92.7% | +4020.5% | -78.8% | +450.9% |
XENE CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $160.70K(+273.7%) | $1.53M(-46.8%) |
| Mar 2025 | - | $43.00K(-94.1%) | $2.87M(-4.8%) |
| Dec 2024 | $3.08M(-45.3%) | $729.30K(+23.0%) | $3.01M(+31.7%) |
| Sep 2024 | - | $593.10K(-60.5%) | $2.29M(-21.2%) |
| Jun 2024 | - | $1.50M(+698.9%) | $2.90M(-18.2%) |
| Mar 2024 | - | $188.00K(+4720.5%) | $3.55M(-36.3%) |
| Dec 2023 | $5.62M(+94.1%) | $3900.00(-99.7%) | $5.57M(-22.9%) |
| Sep 2023 | - | $1.21M(-43.8%) | $7.22M(+13.2%) |
| Jun 2023 | - | $2.15M(-2.6%) | $6.38M(+33.7%) |
| Mar 2023 | - | $2.21M(+33.4%) | $4.77M(+71.9%) |
| Dec 2022 | $2.89M(+41.2%) | $1.65M(+348.3%) | $2.78M(+70.1%) |
| Sep 2022 | - | $368.80K(-31.8%) | $1.63M(+11.9%) |
| Jun 2022 | - | $541.00K(+155.2%) | $1.46M(-21.0%) |
| Mar 2022 | - | $212.00K(-58.4%) | $1.85M(-9.4%) |
| Dec 2021 | $2.05M(-22.3%) | $509.70K(+160.3%) | $2.04M(-15.4%) |
| Sep 2021 | - | $195.80K(-78.9%) | $2.41M(-20.9%) |
| Jun 2021 | - | $929.40K(+130.0%) | $3.05M(+23.3%) |
| Mar 2021 | - | $404.00K(-54.1%) | $2.47M(-9.0%) |
| Dec 2020 | $2.64M(+112.7%) | $881.00K(+5.9%) | $2.71M(+11.7%) |
| Sep 2020 | - | $832.20K(+135.0%) | $2.43M(+47.3%) |
| Jun 2020 | - | $354.20K(-45.3%) | $1.65M(+5.8%) |
| Mar 2020 | - | $647.00K(+8.4%) | $1.56M(+25.0%) |
| Dec 2019 | $1.24M | $596.60K(+1051.7%) | $1.25M(+52.8%) |
| Sep 2019 | - | $51.80K(-80.3%) | $815.70K(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $263.10K(-21.5%) | $780.90K(+19.8%) |
| Mar 2019 | - | $335.00K(+102.1%) | $651.60K(+30.9%) |
| Dec 2018 | $507.00K(+61.0%) | $165.80K(+875.3%) | $497.60K(+27.6%) |
| Sep 2018 | - | $17.00K(-87.3%) | $390.10K(-2.5%) |
| Jun 2018 | - | $133.80K(-26.1%) | $400.30K(+9.5%) |
| Mar 2018 | - | $181.00K(+210.5%) | $365.60K(+13.7%) |
| Dec 2017 | $315.00K(+12.9%) | $58.30K(+114.3%) | $321.60K(+12.8%) |
| Sep 2017 | - | $27.20K(-72.6%) | $285.00K(-5.5%) |
| Jun 2017 | - | $99.10K(-27.7%) | $301.50K(-8.9%) |
| Mar 2017 | - | $137.00K(+531.3%) | $331.00K(+19.5%) |
| Dec 2016 | $279.00K(-49.4%) | $21.70K(-50.3%) | $277.00K(-29.6%) |
| Sep 2016 | - | $43.70K(-66.0%) | $393.60K(-28.3%) |
| Jun 2016 | - | $128.60K(+54.9%) | $548.60K(+4.1%) |
| Mar 2016 | - | $83.00K(-40.0%) | $526.90K(-0.2%) |
| Dec 2015 | $551.00K(-64.0%) | $138.30K(-30.4%) | $527.90K(-52.9%) |
| Sep 2015 | - | $198.70K(+85.9%) | $1.12M(-5.0%) |
| Jun 2015 | - | $106.90K(+27.3%) | $1.18M(+8.2%) |
| Mar 2015 | - | $84.00K(-88.5%) | $1.09M(-26.6%) |
| Dec 2014 | $1.53M(+880.1%) | $732.20K(+184.0%) | $1.49M(+97.0%) |
| Sep 2014 | - | $257.80K(+1416.5%) | $754.80K(+51.9%) |
| Jun 2014 | - | $17.00K(-96.5%) | $497.00K(+3.5%) |
| Mar 2014 | - | $480.00K | $480.00K |
| Dec 2013 | $156.00K(-70.3%) | - | - |
| Dec 2012 | $526.00K(+81.4%) | - | - |
| Dec 2011 | $290.00K | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual capital expenditures?
- What is the all time high annual CAPEX for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual CAPEX year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly CAPEX year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM CAPEX year-on-year change?
What is Xenon Pharmaceuticals Inc. annual capital expenditures?
The current annual CAPEX of XENE is $3.08M
What is the all time high annual CAPEX for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual capital expenditures is $5.62M
What is Xenon Pharmaceuticals Inc. annual CAPEX year-on-year change?
Over the past year, XENE annual capital expenditures has changed by -$2.54M (-45.26%)
What is Xenon Pharmaceuticals Inc. quarterly capital expenditures?
The current quarterly CAPEX of XENE is $160.70K
What is the all time high quarterly CAPEX for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly capital expenditures is $2.21M
What is Xenon Pharmaceuticals Inc. quarterly CAPEX year-on-year change?
Over the past year, XENE quarterly capital expenditures has changed by -$1.34M (-89.30%)
What is Xenon Pharmaceuticals Inc. TTM capital expenditures?
The current TTM CAPEX of XENE is $1.53M
What is the all time high TTM CAPEX for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM capital expenditures is $7.22M
What is Xenon Pharmaceuticals Inc. TTM CAPEX year-on-year change?
Over the past year, XENE TTM capital expenditures has changed by -$1.38M (-47.41%)